Atlas Trials

Remimazolam for Postoperative Atrial Fibrillation

Clinical trial NCT05891145 · RECRUITING

Trial details

NCT number
NCT05891145
Sponsor
Yangzhou University
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Coronary Artery Bypass GraftingRemimazolam
Start date
2023-02-01
Primary completion
2026-12-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.